Cardiovascular Risks in Women with Polycystic Ovary Syndrome: A Narrative Review

    July 2025 in “ Journal of Clinical Research and Reports ”
    Ramina Fazeli
    Image of study
    TLDR Women with PCOS have a higher risk of heart disease.
    This narrative review examines the elevated cardiovascular risks in women with Polycystic Ovary Syndrome (PCOS), a condition affecting 5%-20% of women of reproductive age. It highlights that women with PCOS are approximately 1.66 times more likely to develop cardiovascular disease compared to those without PCOS. The review discusses how factors such as obesity, insulin resistance, hyperandrogenism, and dyslipidemia contribute to cardiovascular dysfunction, leading to conditions like hypertension, stroke, and heart failure. It underscores the importance of early diagnosis and management, including weight management and comprehensive screening, to mitigate long-term health consequences such as Type 2 diabetes and cardiovascular disease. The review also notes the role of genetic, hormonal, and environmental factors in exacerbating these risks and emphasizes the need for increased public awareness and timely medical intervention.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 21 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 year ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 6 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

      community C’est terrible - at my wits end

      in Female  450 upvotes 2 years ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

    Similar Research

    6 / 1000+ results